| Typicality: | 0.455 |
| Saliency: | 0.686 |
| for treatment of separation anxiety | 7 | purpose |
| in the us | 4 | location |
| in december | 2 | temporal |
| fluoxetine → be approved by → the fda | 12 |
| fluoxetine → be approved for → use | 4 |
| fluoxetine → be → approved | 4 |
| fluoxetine → be → fda-approved | 3 |
| fluoxetine → be approved by → the food and drug administration | 3 |
| negative | neutral | positive |
| 0.048 | 0.466 | 0.486 |
| Raw frequency | 26 |
| Normalized frequency | 0.686 |
| Modifier score | 0.500 |
| Perplexity | 12.797 |